Low FT3 is an independent marker of disease severity in patients hospitalized for COVID-19.

Dutta, Aditya; Jevalikar, Ganesh; Sharma, Rutuja; Farooqui, Khalid J; Mahendru, Shama; Dewan, Arun; Bhudiraja, Sandeep; Mithal, Ambrish

Dutta, Aditya; Jevalikar, Ganesh; Sharma, Rutuja; Farooqui, Khalid J; Mahendru, Shama; Dewan, Arun; Bhudiraja, Sandeep; Mithal, Ambrish.

Afiliação

Dutta A; Institute of Endocrinology and Diabetes, Max Healthcare, Saket, New Delhi, India.
Jevalikar G; Institute of Endocrinology and Diabetes, Max Healthcare, Saket, New Delhi, India.
Sharma R; Institute of Endocrinology and Diabetes, Max Healthcare, Saket, New Delhi, India.
Farooqui KJ; Institute of Endocrinology and Diabetes, Max Healthcare, Saket, New Delhi, India.
Mahendru S; Institute of Endocrinology and Diabetes, Max Healthcare, Saket, New Delhi, India.
Dewan A; Institute of Internal Medicine, Max Healthcare, Saket, New Delhi, India.
Bhudiraja S; Institute of Internal Medicine, Max Healthcare, Saket, New Delhi, India.
Mithal A; Institute of Endocrinology and Diabetes, Max Healthcare, Saket, New Delhi, India.

Endocr Connect ; 10(11): 1455-1462, 2021 Nov 11.

Article em En | MEDLINE | ID: mdl-34662295

Palavras-chave

COVID-19; hypothyroidism; low FT3; non-thyroidal illness; severity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google